NASDAQ:LYRA

Lyra Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy LYRA

*Your capital is at risk

$0.495

+0 (+0%)

At Close: Jun 03, 2026

Lyra Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 1.85. In total, the insiders bought 17.8M and sold 126.54K LYRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	1.85
● Buy	17.8M shares
● Sell	126.54K shares
79% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jun 01, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 30, 2023 Buy	Stock Option A-Award	Snyderman Nancy Lynn Md Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Snyderman Nancy Lynn Md Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Anderson Edward T	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Merrifield C Ann Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Altman Michael Seth Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Poukalov Konstantin Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Smith W Bradford Director	Director	20 000 Value: $82.2K
Jun 30, 2023 Buy	Stock Option A-Award	Tobin James R Director	Director	20 000 Value: $82.2K
Jun 15, 2023 Buy	Stock Option A-Award	Palasis Maria President & CEO	CEO / President	150 000 Value: $448.5K
Jun 15, 2023 Buy	Stock Option A-Award	Palasis Maria President & CEO	CEO / President	150 000 Value: $448.5K
Jun 15, 2023 Buy	Stock Option A-Award	Palasis Maria President & CEO	CEO / President	150 000 Value: $448.5K
Jun 15, 2023 Buy	Stock Option A-Award	Palasis Maria President & CEO	CEO / President	150 000 Value: $448.5K
May 31, 2023 Buy	Common Stock P-Purchase	Perceptive Advisors Llc	Director	3 610 832 Value: $9.00M
May 31, 2023 Buy	Common Stock Purchase Warrant P-Purchase	Perceptive Advisors Llc	Director	1 805 416 Value: $4.83M
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Anderson Edward T	Director	98 973 Value: $264.6K
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Anderson Edward T	Director	201 929 Value: $539.8K
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Anderson Edward T	Director	601 806 Value: $1.61M
May 31, 2023 Buy	Common Stock P-Purchase	Anderson Edward T	Director	197 946 Value: $481.0K
May 31, 2023 Buy	Common Stock P-Purchase	Anderson Edward T	Director	403 858 Value: $981.4K
May 31, 2023 Buy	Common Stock P-Purchase	Anderson Edward T	Director	1 203 612 Value: $2.92M
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Nbvm Gp, Llc 10 Percent Owner	10% Owner	98 973 Value: $264.6K
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Nbvm Gp, Llc 10 Percent Owner	10% Owner	201 929 Value: $539.8K
May 31, 2023 Buy	Warrant to purchase Common Stock P-Purchase	Nbvm Gp, Llc 10 Percent Owner	10% Owner	601 806 Value: $1.61M
May 31, 2023 Buy	Common Stock P-Purchase	Nbvm Gp, Llc 10 Percent Owner	10% Owner	197 946 Value: $481.0K
May 31, 2023 Buy	Common Stock P-Purchase	Nbvm Gp, Llc 10 Percent Owner	10% Owner	403 858 Value: $981.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT LYRA THERAPEUTICS INC.

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflam...

Read Full Profile Here